Search Results - Martino Introna

Refine Results
  1. 1
    Innovative Clinical Perspectives for CIK Cells in Cancer Patients

    Innovative Clinical Perspectives for CIK Cells in Cancer Patients by Martino Introna, Fabio Correnti

    Published 2018
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    The specific Bruton tyrosine kinase inhibitor acalabrutinib (ACP-196) shows favorable <i>in vitro</i> activity against chronic lymphocytic leukemia B cells with CD20 antibodies

    The specific Bruton tyrosine kinase inhibitor acalabrutinib (ACP-196) shows favorable <i>in vitro</i> activity against chronic lymphocytic leukemia B cells with CD20 antibodies by Josée Golay, Greta Ubiali, Martino Introna

    Published 2017
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  3. 3
    INHIBITION OF HUMAN NATURAL KILLER ACTIVITY BY CYCLOSPORIN A

    INHIBITION OF HUMAN NATURAL KILLER ACTIVITY BY CYCLOSPORIN A by Martino Introna, Paola Allavena, Federico Spreafico, Alberto Mantovani

    Published 1981
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches

    Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches by Alessandro Rambaldi, E. Biagi, Chiara Bonini, Andrea Biondi, Martino Introna

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines

    B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines by Marcello Arsura, Martino Introna, F Passerini, Alberto Mantovani, Josée Golay

    Published 1992
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines

    B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines by Marcello Arsura, Martino Introna, F Passerini, Alberto Mantovani, Josée Golay

    Published 1992
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Enhanced killing of human B-cell lymphoma targets by combined use of cytokine-induced killer cell (CIK) cultures and anti-CD20 antibodies

    Enhanced killing of human B-cell lymphoma targets by combined use of cytokine-induced killer cell (CIK) cultures and anti-CD20 antibodies by Alice Pievani, Camilla Belussi, Christian Klein, Alessandro Rambaldi, Josée Golay, Martino Introna

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    The Cytolytically Inactive Terminal Complement Complex Activates Endothelial Cells to Express Adhesion Molecules and Tissue Factor Procoagulant Activity

    The Cytolytically Inactive Terminal Complement Complex Activates Endothelial Cells to Express Adhesion Molecules and Tissue Factor Procoagulant Activity by Francesco Tedesco, M. Pausa, Ermanno Nardon, Martino Introna, Alberto Mantovani, Aldo Dobrina

    Published 1997
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells

    Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells by Josée Golay, Adele Capucci, Marcello Arsura, Maurizio Castellano, Virginia Rizzo, Martino Introna

    Published 1991
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Human neutrophils express low levels of FcγRIIIA, which plays a role in PMN activation

    Human neutrophils express low levels of FcγRIIIA, which plays a role in PMN activation by Josée Golay, Rut Valgardsdottir, Adanela Musaraj, Damiano Giupponi, Orietta Spinelli, Martino Introna

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes

    Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes by VV Alles, Barbara Bottazzi, Giuseppe Peri, Josée Golay, Martino Introna, Alberto Mantovani

    Published 1994
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    The effect of LPS on expression of the early "competence" genes JE and KC in murine peritoneal macrophages.

    The effect of LPS on expression of the early "competence" genes JE and KC in murine peritoneal macrophages. by Martino Introna, Robert C. Bast, Charles S. Tannenbaum, Thomas A. Hamilton, Dolph O. Adams

    Published 1987
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Treatment of murine peritoneal macrophages with bacterial lipopolysaccharide alters expression of c-fos and c-myc oncogenes.

    Treatment of murine peritoneal macrophages with bacterial lipopolysaccharide alters expression of c-fos and c-myc oncogenes. by Martino Introna, Thomas A. Hamilton, Russel E. Kaufman, Dolph O. Adams, Robert C. Bast

    Published 1986
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Inhibition of natural killer activity by human bronchoalveolar macrophages.

    Inhibition of natural killer activity by human bronchoalveolar macrophages. by Claudio Bordignon, Federico Villa, Paola Allavena, Martino Introna, Andrea Biondi, Roberta Avallone, Alberto Mantovani

    Published 1982
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Cytokine-induced killer cells are terminallydifferentiated activated CD8 cytotoxic T-EMRA lymphocytes

    Cytokine-induced killer cells are terminallydifferentiated activated CD8 cytotoxic T-EMRA lymphocytes by Marta Franceschetti, Alice Pievani, Gianmaria Borleri, Luca Vago, Katharina Fleischhauer, Josée Golay, Martino Introna

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Mechanism of Action of Type II, Glycoengineered, Anti-CD20 Monoclonal Antibody GA101 in B-Chronic Lymphocytic Leukemia Whole Blood Assays in Comparison with Rituximab and Alemtuzumab

    Mechanism of Action of Type II, Glycoengineered, Anti-CD20 Monoclonal Antibody GA101 in B-Chronic Lymphocytic Leukemia Whole Blood Assays in Comparison with Rituximab and Alemtuzum... by Luca Bologna, Elisa Gotti, Massimiliano Manganini, Alessandro Rambaldi, Tamara Intermesoli, Martino Introna, Josée Golay

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity

    Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity by Alice Pievani, Gianmaria Borleri, Daniela Pende, Lorenzo Moretta, Alessandro Rambaldi, Josée Golay, Martino Introna

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Ofatumumab Is More Efficient than Rituximab in Lysing B Chronic Lymphocytic Leukemia Cells in Whole Blood and in Combination with Chemotherapy

    Ofatumumab Is More Efficient than Rituximab in Lysing B Chronic Lymphocytic Leukemia Cells in Whole Blood and in Combination with Chemotherapy by Luca Bologna, Elisa Gotti, Fabio Da Roit, Tamara Intermesoli, Alessandro Rambaldi, Martino Introna, Josée Golay

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes.

    Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes. by Francesco Colotta, Simona Saccani, Judith G. Giri, Steven Dower, John E. Sims, Martino Introna, Alberto Mantovani

    Published 1996
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59

    CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59 by Josée Golay, Manuela Lazzari, Valeria Facchinetti, Sergio Bernasconi, Gianmaria Borleri, Tiziano Barbui, Alessandro Rambaldi, Martino Introna

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: